150378-17-9 Indinavir AKSci E104
 
 
Loading Please Wait...
  E104    AKSci Reference Standard
Indinavir
, 98% (HPLC), powder
 
2,3,5-Trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl)-1-piperazinyl]-2-(phenylmethyl)-D-erythro-pentonamide sulfate hydrate
Crixivan hydrate




IDENTITY
CAS Number:150378-17-9
MDL Number:MFCD00866938
MF:C36H47N5O4
MW:613.79
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:98% (HPLC), powder
Physical Form (at 20°C):Solid
Melting Point:150-159°C
Optical Rotation:+24.1° (c=0.0133, chloroform)
Long-Term Storage:Store long-term at 2-8°C
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

BIOLOGICAL INFO
Solubility:Water: 0.015 mg/mg (unbuffered)

REVIEW

 Indinavir is a HIV-1 protease inhibitor which inhibits the HIV viral protease enzyme, preventing cleavage of the viral gag-pol polyprotein, resulting in the formation of noninfectious, immature viral particles. Indinavir is used as a component of highly active antiretroviral therapy (HAART) to treat HIV infection and AIDS.

REFERENCES
[1]Boyd M. Indinavir: the forgotten HIV-protease inhibitor. Does it still have a role? Expert Opin Pharmacother (2007)8(7):957-64.
[2] Plosker GL, Noble S. Indinavir: a review of its use in the management of HIV infection. Drugs. (1999), 58(6), 1165-203.
[3] Pradier C, Pesce A, Carrieri P, Cottalorda J, Boyer P, Senesi C, Fuzibet JG, Dellamonica P, Cassuto JP :Effect of indinavir and higher CD4+ T-cell count on viral load response after 6 months of highly active antiretroviral therapy. Clin Ther. (1999)21(8):1313-20.
[4] Lacy MK, Abriola KP. Indinavir: a pharmacologic and clinical review of a new HIV protease inhibitor. Conn Med. (1996), 60(12):723-7.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Warning

Hazard Statements
H315; H319; H335

Precautionary Statements
P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501


Current as of March 26, 2023

AKSci Reference Standards are high-purity, low-impurity compounds suitable for use as standards.


Download SDS Request COA

⚠️
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information.



CATEGORIES

 APIs and Bioactives > Antivirals, HIV Protease Inhibitors


PubChem
  @PubMed